Highly purified sodium hyaluronate for viscoelastic replenishment or replacement of synovial fluid, and for the symptoms of osteoarthritis.
Hyaluronic acid is a major component of synovial fluid and cartilage. SkyVisc Pure is similar to synovial fluid; it replaces what the joint has lost, increasing mobility and providing pain relief.
| Composition | Sodium hyaluronate in phosphate buffer |
|---|---|
| Bond structure | Linear |
| Hyaluronic acid concentration | 10 – 30 mg/mL |
| Variants | 10 · 14 · 15 · 20 · 24 · 25 · 30 mg/mL |
| Syringe | 1 · 2 · 2.5 · 3 · 4 · 5 mL |
| Flacon | — |
| Dosing | Per physician |
| Buffer | Sodium dihydrogen phosphate · disodium hydrogen phosphate · sodium chloride |
| Form | Sterile viscoelastic solution |
| Use | Single use only |
| Shelf life | 2 years |
| Storage | Between 2 °C and 25 °C |
| Marking | CE |
Refer to the Instructions for Use for the full intended purpose, contraindications and warnings.
SkyVisc is a range of four intra-articular grades. Pure is hyaluronic acid alone; + and GGP add actives to the linear gel; Cross is the single cross-linked model. SkyVisc + · SkyVisc GGP · SkyVisc Cross · Full SkyVisc range
SkyVisc Pure is the base grade of the SkyVisc intra-articular range: highly purified sodium hyaluronate in phosphate buffer, with no additives, in a linear gel.
Seven concentrations (10, 14, 15, 20, 24, 25 and 30 mg/mL) in six pre-filled syringe sizes (1, 2, 2.5, 3, 4 and 5 mL). Every concentration is offered in every size.
Between 2 °C and 25 °C. The shelf life is 2 years.
Pure is hyaluronic acid alone. SkyVisc + adds L-proline, SkyVisc GGP adds L-proline, glycine and N-acetyl glucosamine, and SkyVisc Cross is the cross-linked model.
Technical specifications, regulatory documentation and catalogs are available to qualified partners on request.
Product information is provided for healthcare professionals, distributors and business partners and does not constitute medical advice. Availability, specifications and regulatory status may vary by country.